疫苗股集体大涨,海外新冠疫苗涨价潮要来了?

华尔街见闻2022-10-22

作者:韩旭阳随着疫苗将从美国联邦政府管理的体系转入商业市场,海外新冠疫苗或将迎来一波涨价潮。10月20日,辉瑞公司透露,将提高其新冠疫苗的商业售价,预计其疫苗价格将涨至每剂110美元至130美元。按照这一商业售价的中间值120美元计算,这是美国政府采购价(每剂疫苗约为30美元)的4倍,市场预期其营收将会大幅增长。周五,辉瑞股价以近5%的涨幅收盘。从2023年开始,新冠疫苗将从美国政府采购过渡到典型...

Source Link
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Leave a comment
5